Development of an HPLC assay to study the effect of endogenous and exogenous substances on heat-induced aggregation of human serum albumin

Clinical Chemistry and Laboratory Medicine

Volumn 36, Issue 3, 1998, Pages 155-162

  Saso, Luciano ^a   Casini, Maria Luisa ^a   Valentini, Giovanni ^a   Mattei, Eleonora ^a   Panzironi, Claudio ^a   Silvestrini, Bruno ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Albumin; Anti denaturant agents; Anti rheumatic drugs; Denaturation; High performance liquid chromatography; Non steroidal anti inflammatory drugs

Indexed keywords

ANTIRHEUMATIC AGENT; BILIRUBIN; DICLOFENAC; FORMIC ACID; FUMARIC ACID; HUMAN SERUM ALBUMIN; IBUPROFEN; MALEIC ACID; MALONIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; SODIUM CHLORIDE; STABILIZING AGENT; SUCCINIC ACID;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENATURATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; TURBIDIMETRY;

ACIDS, ACYCLIC; ALBUMINS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BILIRUBIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOOXYGENASE INHIBITORS; DICARBOXYLIC ACIDS; DICLOFENAC; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEAT; HUMANS; IBUPROFEN; NAPROXEN; NEPHELOMETRY AND TURBIDIMETRY; PROTEIN DENATURATION; SERUM ALBUMIN; SODIUM CHLORIDE;

EID: 0031922392     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1998.029     Document Type: Article

References (28)

1. Peters T. Serum albumin. Adv Protein Chem 1970; 13:37-111.
2. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol Rev 1981; 33:17-54.
3. Peters T. Serum albumin. Adv Protein Chem 1985; 37:161-245.
4. Carter D, Ho JX. Structure of serum albumin. Adv Protein Chem 1994; 45:153-203.
5. Mizushima Y. Inhibition of protein denaturation by antirheumatic or antiphlogistic agents. Arch Int Pharmacol 1964; 149:1-7.
6. Silvestrini B, Cioli V, Burberi S. Pharmacological properties of bendazac (AF 983) with particular reference to its topical action on some experimental inflammatory processes. Arzneim Forsch 1969; 19:30-6.
7. Opie EL. On the relation of inflammation to the chemical constitution of injurious agents; on the pharmacology of inflammation. J Exp Med 117:425-48.
8. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol) 1971; 231:232-5.
9. Abramson SR, Weissmann G. The mechanisms of action of nonsteroidal anti-inflammatory drugs. Arthritis Rheum 1989; 32:1-9.
10. Insel PA. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. Goodman and Gilman's. The pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996:617-57.
11. Silvestrini B. Rationale for bendazac. In: D'Ermo F, Ponte F, editors. Recent developments in the pharmacological treatment of cataract. Amsterdam: Kugler, 1987:1-9.
12. Cioli V, Ciarniello MG, Guglielmotti A, Luparini MR, Durando L, Martinelli B, et al. A new protein anti-denaturant agent, bindarit, reduces secondary phase of adjuvant arthritis in rats. J Rheumatol 1992; 19:1735-42.
13. Lohner K, Sen AC, Prankerd R, Esser AF, Perrin JH. Effects of drug-binding on the thermal denaturation of human serum albumin. J Pharm Biomed Anal 1994; 12:1501-5.
14. Nargund LVG, Hariprasad V, Reddy GRN. Synthesis and anti-inflammatory activity of fluorinated phenyl styryl ketones and N-phenyl-5-substituted aryl-3-p-(fluorophenyl) pyrazolins and pyrazoles. J Pharm Sci 1992; 81:892-4.
15. Ballou GA, Boyer PD, Luck JM, Lum FG. The heat coagulation of human serum albumin. J Biol Chem 1944; 153:589-605.
16. Boyer PD, Lum FG, Ballou GA, Luck JM, Rice RG. The combination of fatty acids and related compounds with serum albumin. J Biol Chem 1946; 162:181-98.
17. Katz S, Shinaberry RG, Heck EL, Squire, W. Structure-volume relationships: singular volume effects produced by cupric ion-globular protein interaction. Biochemistry 1980; 19:3805-13.
18. Gumpen S, Hegg PO, Martens H. Thermal stability of fatty acid-serum albumin complexes studied by differential scanning calorimetry. Biochem Biophys Acta 1979; 574:189-96.
19. Putnam FW. The interactions of proteins and synthetic detergents. Adv Protein Chem 1948; 4:79-122.
20. Tanford C. Protein denaturation. Adv Protein Chem 1968; 23:121-282.
21. Neuberg C. Hydrotropy. Biochem Z 1916;76:106-76.
22. Saleh AM, Forence AT, Whateley TL, El-Khordagui LK. The effect of hydrotropic agents on the heat coagulation of bovine serum albumin. J Pharm Pharmacol 1989; 41:298-301.
23. Saso L, Casini ML, Valentini G, Alcaro S, Silvestrini B. Effect of selected substances on heat induced aggregation of albumin examined by HPLC and polyacrylamide gel electrophoresis [abstract]. Pharmacol Res 1995; 31 (Suppl), 214 S.
24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
25. Tallarida RJ, Murray RB. Manual of pharmacologic calculations with computer programs. New York: Springer-Verlag, 1986.
26. Lombardino JG. Nonsteroidal anti-inflammatory drugs. New York: John Wiley & Sons, 1985.
27. Lovrien R. Interaction of dodecyl sulfate anions of low concentration with alkaline bovine serum albumin. J Am Chem Soc 1963; 85:3677-82.
28. Markus G, Love RL, Wissler FC. Mechanism of protection by anionic detergents against denaturation of serum albumin. J Biol Chem 1964; 239:3687-93.